ICU Medical 2016 Hospira Infusion Systems Acquisition

ICU Medical's investor presentation outlining the acquisition of Pfizer's Hospira Infusion Systems business for $1 billion in cash and stock. The transaction will create a leading pure-play infusion therapy company with approximately $1.45 billion in pro forma revenues, expected to close in Q1 2017.